Logo image of AMBO

AMBOW EDUCATION HOLDING-ADR (AMBO) Stock Fundamental Analysis

NYSEARCA:AMBO - NYSE Arca - US02322P3091 - ADR - Currency: USD

2.63  +0.07 (+2.94%)

Fundamental Rating

3

AMBO gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 73 industry peers in the Diversified Consumer Services industry. AMBO has an average financial health and profitability rating. AMBO does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

In the past year AMBO was profitable.
AMBO had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: AMBO reported negative net income in multiple years.
In multiple years AMBO reported negative operating cash flow during the last 5 years.
AMBO Yearly Net Income VS EBIT VS OCF VS FCFAMBO Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M -10M -20M -30M

1.2 Ratios

The Return On Assets of AMBO (1.78%) is better than 63.01% of its industry peers.
The Return On Equity of AMBO (4.59%) is better than 63.01% of its industry peers.
Industry RankSector Rank
ROA 1.78%
ROE 4.59%
ROIC N/A
ROA(3y)-23.58%
ROA(5y)-15.22%
ROE(3y)-76.96%
ROE(5y)-54.06%
ROIC(3y)N/A
ROIC(5y)N/A
AMBO Yearly ROA, ROE, ROICAMBO Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50 -100 -150

1.3 Margins

AMBO has a better Profit Margin (3.29%) than 64.38% of its industry peers.
AMBO's Profit Margin has improved in the last couple of years.
The Gross Margin of AMBO (53.10%) is better than 67.12% of its industry peers.
In the last couple of years the Gross Margin of AMBO has grown nicely.
Industry RankSector Rank
OM N/A
PM (TTM) 3.29%
GM 53.1%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y7.59%
PM growth 5YN/A
GM growth 3Y69.42%
GM growth 5Y9.72%
AMBO Yearly Profit, Operating, Gross MarginsAMBO Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50 -50

More info and screens

4

2. Health

2.1 Basic Checks

AMBO does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for AMBO remains at a similar level compared to 1 year ago.
The number of shares outstanding for AMBO has been increased compared to 5 years ago.
The debt/assets ratio for AMBO has been reduced compared to a year ago.
AMBO Yearly Shares OutstandingAMBO Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500K 1M 1.5M 2M 2.5M
AMBO Yearly Total Debt VS Total AssetsAMBO Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

AMBO has an Altman-Z score of -39.97. This is a bad value and indicates that AMBO is not financially healthy and even has some risk of bankruptcy.
AMBO has a Altman-Z score of -39.97. This is amonst the worse of the industry: AMBO underperforms 87.67% of its industry peers.
AMBO has a debt to FCF ratio of 6.21. This is a slightly negative value and a sign of low solvency as AMBO would need 6.21 years to pay back of all of its debts.
AMBO has a better Debt to FCF ratio (6.21) than 69.86% of its industry peers.
AMBO has a Debt/Equity ratio of 0.40. This is a healthy value indicating a solid balance between debt and equity.
Looking at the Debt to Equity ratio, with a value of 0.40, AMBO is in line with its industry, outperforming 45.21% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 6.21
Altman-Z -39.97
ROIC/WACCN/A
WACC8.56%
AMBO Yearly LT Debt VS Equity VS FCFAMBO Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M

2.3 Liquidity

AMBO has a Current Ratio of 1.70. This is a normal value and indicates that AMBO is financially healthy and should not expect problems in meeting its short term obligations.
AMBO has a better Current ratio (1.70) than 65.75% of its industry peers.
A Quick Ratio of 1.70 indicates that AMBO should not have too much problems paying its short term obligations.
AMBO's Quick ratio of 1.70 is fine compared to the rest of the industry. AMBO outperforms 71.23% of its industry peers.
Industry RankSector Rank
Current Ratio 1.7
Quick Ratio 1.7
AMBO Yearly Current Assets VS Current LiabilitesAMBO Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

1

3. Growth

3.1 Past

AMBO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 109.57%, which is quite impressive.
AMBO shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -60.85% yearly.
AMBO shows a small growth in Revenue. In the last year, the Revenue has grown by 2.50%.
The Revenue for AMBO have been decreasing by -35.56% on average. This is quite bad
EPS 1Y (TTM)109.57%
EPS 3Y-60.85%
EPS 5YN/A
EPS Q2Q%109.57%
Revenue 1Y (TTM)2.5%
Revenue growth 3Y-18.89%
Revenue growth 5Y-35.56%
Sales Q2Q%2.5%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
AMBO Yearly Revenue VS EstimatesAMBO Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 23.91, the valuation of AMBO can be described as rather expensive.
Compared to the rest of the industry, the Price/Earnings ratio of AMBO indicates a somewhat cheap valuation: AMBO is cheaper than 61.64% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of AMBO to the average of the S&P500 Index (28.78), we can say AMBO is valued inline with the index average.
Industry RankSector Rank
PE 23.91
Fwd PE N/A
AMBO Price Earnings VS Forward Price EarningsAMBO Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

AMBO's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. AMBO is cheaper than 90.41% of the companies in the same industry.
78.08% of the companies in the same industry are more expensive than AMBO, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 17.15
EV/EBITDA 4.32
AMBO Per share dataAMBO EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

AMBO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

AMBOW EDUCATION HOLDING-ADR

NYSEARCA:AMBO (4/25/2025, 8:04:00 PM)

2.63

+0.07 (+2.94%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupConsumer Services
GICS IndustryDiversified Consumer Services
Earnings (Last)04-01 2024-04-01/amc
Earnings (Next)N/A N/A
Inst Owners0%
Inst Owner Change0%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap7.46M
Analysts0
Price TargetN/A
Short Float %0.5%
Short Ratio0.25
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 23.91
Fwd PE N/A
P/S 0.79
P/FCF 17.15
P/OCF 4.56
P/B 1.11
P/tB 1.2
EV/EBITDA 4.32
EPS(TTM)0.11
EY4.18%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.15
FCFY5.83%
OCF(TTM)0.58
OCFY21.92%
SpS3.31
BVpS2.38
TBVpS2.19
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.78%
ROE 4.59%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 3.29%
GM 53.1%
FCFM 4.63%
ROA(3y)-23.58%
ROA(5y)-15.22%
ROE(3y)-76.96%
ROE(5y)-54.06%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y7.59%
PM growth 5YN/A
GM growth 3Y69.42%
GM growth 5Y9.72%
F-Score8
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 6.21
Debt/EBITDA 1.84
Cap/Depr 54.79%
Cap/Sales 12.78%
Interest Coverage N/A
Cash Conversion 111.38%
Profit Quality 140.78%
Current Ratio 1.7
Quick Ratio 1.7
Altman-Z -39.97
F-Score8
WACC8.56%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)109.57%
EPS 3Y-60.85%
EPS 5YN/A
EPS Q2Q%109.57%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2.5%
Revenue growth 3Y-18.89%
Revenue growth 5Y-35.56%
Sales Q2Q%2.5%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y83.23%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y250%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y663.79%
OCF growth 3YN/A
OCF growth 5YN/A